Discovery of a more potent anticancer agent than C4-benzazole 1,8-naphthalimide derivatives against murine melanoma | |
---|---|
學年 | 108 |
學期 | 2 |
出版(發表)日期 | 2020-07-11 |
作品名稱 | Discovery of a more potent anticancer agent than C4-benzazole 1,8-naphthalimide derivatives against murine melanoma |
作品名稱(其他語言) | |
著者 | Chi-Hua Tung; Yen-Ta Lu; Wei-Ting Kao; Jen-Wei Liu; Yi-Hsuan Lai; Shinn-Jong Jiang; Hao-Ping Chen; Tzenge-Lien Shih |
單位 | |
出版者 | |
著錄名稱、卷期、頁數 | Journal of the Chinese Chemical Society 67(7), p.1254-1262 |
摘要 | Three novel naphthalimide‐based derivatives were synthesized and tested in vitro as anticancer agents. Our previous report of the C4‐benzazole 1,8‐naphthalimide derivatives showed good inhibition against murine melanoma. We aimed to synthesize more potent agents and found that compound 5 reported in this article behaved 5‐ to 10‐fold potency than our previous best results. The unique structure of compound 5 consisted of a naphthalimide framework in which C4 position was linked with an ethylenediamine group where the amino group was coupled with a 2‐piconic acid moiety. Compound 5 exhibited the most potent inhibitory activity toward human DNA topoisomerase II proteins with IC50 value (2.6 ± 0.1 μM) against murine B16F10 melanoma cells among the three target compounds synthesized in this study. In accordance with this finding, the results of molecular docking also revealed that compound 5 has the highest affinity with human DNA topoisomerase II among the selected compounds. Compound 5 , therefore, has high potential for becoming a lead compound. |
關鍵字 | |
語言 | en |
ISSN | |
期刊性質 | 國外 |
收錄於 | SCI |
產學合作 | |
通訊作者 | |
審稿制度 | 是 |
國別 | GBR |
公開徵稿 | |
出版型式 | ,電子版 |
相關連結 |
機構典藏連結 ( http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/118898 ) |
SDGS | 良好健康和福祉,優質教育 |